Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products
Expert Opin Drug Saf
.
2022 Feb;21(2):285-287.
doi: 10.1080/14740338.2021.1983312.
Epub 2021 Oct 7.
Authors
Nasr Eldin Hussein Nasr
1
,
Metwaly Gamel Metwaly
1
,
Eman Osama Ahmed
1
,
Ahmed Roshdy Fares
2
,
Aliaa Nabil ElMeshad
2
3
Affiliations
1
Research and Development Department, Al Esraa Pharmaceutical Optima, Badr City, Cairo, Egypt.
2
Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
3
Faculty of Nanotechnology for Postgraduate Studies, Cairo University, El-Sheikh Zayed, Giza, Egypt.
PMID:
34546846
DOI:
10.1080/14740338.2021.1983312
No abstract available
MeSH terms
Dimethylnitrosamine / analysis*
Drug Contamination / prevention & control*
Humans
Metformin / analysis*
Substances
Metformin
Dimethylnitrosamine